Evidence map›Paper›PMID 36408467›Full record

ArticleOpen forum infectious diseases2022

Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients.

Jens T Van Praet, Marie De Groote, Dirk De Bacquer, Ellen Verhalleman, Ziggy Welvaert, Jan Emmerechts, Marijke Reynders, An S De Vriese

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jens T Van PraetDepartment of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.ORCID https://orcid.org/0000-0002-7125-7001
Marie De GrooteDepartment of Geriatrics, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Dirk De BacquerDepartment of Public Health and Primary Care, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0002-3202-7238
Ellen VerhallemanDepartment of Occupational Therapy, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Ziggy WelvaertDepartment of Occupational Therapy, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Jan EmmerechtsDepartment of Laboratory Hematology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Marijke ReyndersDepartment of Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.ORCID https://orcid.org/0000-0003-2079-1279
An S De VrieseDepartment of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.ORCID https://orcid.org/0000-0002-9596-8529
AZ Sint-Jan · BEGhent University Hospital · BEGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic kidney disease is associated with increased risk of frailty and accelerated immune senescence, potentially affecting the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Methods: Humoral and cellular responses against the spike protein of SARS-CoV-2 were determined in 189 COVID-naive hemodialysis patients at week 4 and 8 after vaccination with 2 doses of BNT162b2. Frailty indicators and immune senescence markers were determined at baseline to identify predictors of the immune response. Results: Controlling for age, activities of daily living (ADLs), instrumental ADLs, walking pace, and the clinical frailty score correlated negatively and hand grip strength positively with the humoral response. Controlling for age, the proportions of memory CD4 Conclusions: Markers of immune senescence, but not frailty indicators, independently predict the cellular immune response after vaccination in hemodialysis patients, overruling the effect of chronological age.

Indexed as

BNT162b2 vaccinationCOVID-19frailtyhemodialysisimmune responseimmune senescenceSARS-CoV-2

Identifiers

PMID36408467
PMCPMC9669454
OpenAlexW4307889848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.